These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25605650)

  • 21. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
    BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
    Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L
    J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation.
    Huang H; Xu X; Yao C; Cai M; Qian Y; Wang X; Shi B
    Mol Med Rep; 2014 Jan; 9(1):45-50. PubMed ID: 24154640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Complexities of the Diagnosis and Management of Kawasaki Disease.
    Rowley AH
    Infect Dis Clin North Am; 2015 Sep; 29(3):525-37. PubMed ID: 26154665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J
    Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
    Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
    Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease.
    Reichardt P; Lehmann I; Sierig G; Borte M
    Infection; 2002 Dec; 30(6):360-4. PubMed ID: 12478326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T; Inoue Y; Takeuchi K; Okada Y; Tamura K; Tomomasa T; Kobayashi T; Morikawa A
    Circulation; 2006 Jun; 113(22):2606-12. PubMed ID: 16735679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY; Lee KY; Rhim JW; Youn YS; Oh JH; Han JW; Lee JS; Burgner D
    Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H
    Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis and management of Kawasaki disease.
    Royle J; Burgner D; Curtis N
    J Paediatr Child Health; 2005 Mar; 41(3):87-93. PubMed ID: 15790316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Roles of CXCR3 on lymphocytes and IP-10 of peripheral blood in infants with bronchiolitis].
    Zou LP; Xu XJ; Zhang Y; Wang W
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Feb; 17(2):155-8. PubMed ID: 25760840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma H2S predicts coronary artery lesions in children with Kawasaki disease.
    Sun Y; Yuan Y; Yan H; Wan H; Li X; Chen S; Li H; Tang C; Du J; Liu G; Jin H
    Pediatr Int; 2015 Oct; 57(5):840-4. PubMed ID: 25808254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
    Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
    Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
    J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.